The expression of heat shock proteins (HSP) of the 65kD family (groEL) has been observed by flow cytometry using murine monoclonal antibody (MoAb) anti-HSP 65kD (ML30) on the surface of B (Daudi) or T (H9) lymphoma cells, on a moncyte cell line (U937) and also on a primary culture of a human pancreatic carcinoma (HPC). Moreover Heat Shock Proteins (HSP) represent a family of highly conserved molecules that under stress conditions play an important physiological role in folding and unfolding of proteins (Lindquist & Craig, 1988) . HSP expression is strictly related to cell cycle and oncogene activation (Pechan, 1991) , and it is important to note that HSP are often tumour associated antigens (Ulrich & Robinson, 1986; Srivistava & Maki, 1990) . In fact, myc-overexpressing cells show viral myc-proteins nuclearly colocalised with nuclear HSP70 (Koshinen et al., 1991). The myc-oncogene is functionally similar to the adenovirus Ela and is able to collaborate with activated ras-oncogene to transform primary fibroblasts (Ralston, 1991) . It has been reported also that the adenoviral Ela products induce HSP70 synthesis by acting as transcriptional activator. However, it is not yet clear whether increased levels of HSP may facilitate tumoural and viral proliferation. In Hela cells, HSP70 interacts with other cellular proteins in a cell cycle-dependent manner; synthesis of HSP has been shown to increase during mitosis (Pechan, 1991) . Other HSP such as HSP90 and HSP70 have been found to reach abnormally high levels in transformed cells (Bensaude & Morange, 1983) . Proteins belonging to the HSP70 family were shown to interact with nuclear oncogenes such as p53, and the stability of this interaction might influence transformation (Finlay et al., 1988 
Heat Shock Proteins (HSP) represent a family of highly conserved molecules that under stress conditions play an important physiological role in folding and unfolding of proteins (Lindquist & Craig, 1988) . HSP expression is strictly related to cell cycle and oncogene activation (Pechan, 1991) , and it is important to note that HSP are often tumour associated antigens (Ulrich & Robinson, 1986; Srivistava & Maki, 1990) . In fact, myc-overexpressing cells show viral myc-proteins nuclearly colocalised with nuclear HSP70 (Koshinen et al., 1991) . The myc-oncogene is functionally similar to the adenovirus Ela and is able to collaborate with activated ras-oncogene to transform primary fibroblasts (Ralston, 1991) . It has been reported also that the adenoviral Ela products induce HSP70 synthesis by acting as transcriptional activator. However, it is not yet clear whether increased levels of HSP may facilitate tumoural and viral proliferation. In Hela cells, HSP70 interacts with other cellular proteins in a cell cycle-dependent manner; synthesis of HSP has been shown to increase during mitosis (Pechan, 1991) . Other HSP such as HSP90 and HSP70 have been found to reach abnormally high levels in transformed cells (Bensaude & Morange, 1983) . Proteins belonging to the HSP70 family were shown to interact with nuclear oncogenes such as p53, and the stability of this interaction might influence transformation (Finlay et al., 1988) . It was also found that high HSP65 expression was not a general feature of all transformed cells, since some cell lines expressed little or non detectable HSP65 protein, while TNF-a and/or IFN--y are able to increase synthesis of HSP in tumour cells (Ferm et al., in press ). Surface expression of HSP is still controversial; some authors have found no evidence for cell surface expression (Ferm et al., in press), whereas others reported cell membrane HSP expression during infection with transforming viruses (La Thangue & Latchman, 1988; Newins, 1982) . We recently reported that H9 cells chronically infected with HIV-1 express membrane HSP70 (Di Cesare et al., in press) . During these studies, we observed that anti-HSP65 and HSP70 monoclonal antibodies were able to mediate antibody dependent cellular cytotoxicity (ADCC) against a large panel of T and B cell lymphomas using human peripheral lymphocytes as effector cells (Poccia et al., submitted 
SCID mice
The SCID mutation (Bosma et al., 1983) cell lines (Moisier et al., 1988 (Ivanyi et al., 1983; Evans et al., 1990) . All cell lines used in this study were checked for mycobacteria contamination by culturing cell line extracts on Sauton medium.
Human sera obtained from healthy donors (Munk et al., 1989) were selected by their positivity for antibodies against human HSP65 by Western blotting, and one positive human serum was used to mediate cytotoxic activity against HSP (Poccia et al., submitted).
Immunotoxin
The ribosome-inactivating protein saporin 6 was prepared as previously described ) from seeds of Saponaria officinalis (kindly supplied from the Azienda Regionale delle Foreste, Regione Emilia-Romagna, Bologna). This protein has the ability to inactivate proteic synthesis cleaving the ribosomal RNA in correspondence of a specific adenine in a highly conserved r-RNA region (adenine 4324 of rat liver r-RNA).
The protein was labelled with 1251I (lodogen reagent, Pierce). Saporin was linked to antibodies as previously described by an artificial disulfide binding introduced with 2-iminothiolane. Briefly, antibodies (ML30, anti-human IgG and IgM, and anti-tenascin BC2) or F(ab')2 fragments of anti-mouse IgG (Sigma, St Louis, MO, USA) and saporin, the latter containing a trace of 1251I saporin, were dissolved in 50mM borate buffer pH9.0 at a concentration of lmgml-' and 6mgml-', respectively, and were modified with 2-iminothialane (2-IT) at a final concentration 0.6mM (antibodies or 0.8-1.0mM (saporin). After 30min at room temperature (22°C), glycine was added to a final concentration at 200mM. After 30min, Ellman's reagent dissolved in 50fd of dimethylformamide was added to a final concentration 2.5mM, and modified proteins were separated from unreacted reagents by gel filtration on a Sephadex-G25 column. The modified saporin was reduced with 50mM 2-dithiothreitol, filtered through a Sephadex G-25 column and mixed with the unmodified antibodies in a saporin ratio of 10: 1. After 24h, the conjugate was separated from unreacted components by gel filtration on a Sephacryl S200 high resolution column. The Saporin/antibody ratio of immunotoxins was calculated from the radioactivity. The inhibitory activity on -protein synthesis was assayed, after reduction of 2-dithiothreitol, on a rabbit reticulocyte lysate as described . Murine MoAb BC2 (anti-tenascin) coupled with saporin was used as immunotoxin control. The concentration providing 50% inhibition of protein synthesis in a rabbit reticulocyte system Immunotoxin dependent inhibition of cellular proliferation Cell proliferation was evaluated using a 3H-thymidine incorporation technique . 102 target cells were resuspended in 100,lI of medium and 100tly of immunotixin at different dilutions (1-03-10-7M) were added.
For the indirect immunotoxin assay, cells were incubated in presence or absence of ML30 (100flgml-') for 30min at 4°C
and washed before the addition of anti-mouse immunotoxin. For the direct immunotoxin assay, the cells were incubated with the anti-HSP65 immunotoxin for 30min at 4°C and then washed. After 90h of incubation at 37°C (control cells were still in logarithmic growth), cells were incubated for 6h with 3H-thymidine (0.5pCi/well, Amersham), harvested and radioactivity measured using a P-counter.
Statistical analysis Student's t-test was performed for analysis of the means. Cell proliferation inhibition assay was analysed using linear regression.
Results

HSP65-specific immunofluorescence on tumour cell lines
The presence of membrane HSP65 has been analysed by flow cytometry using the antiHSP65 MoAb ML30 on T (H9) and B (Daudi) cell lymphomas, on a monocytic cell line (U937) and on HPC, a human pancreatic carcinoma cell line. Table I illustrates the specific fluorescence in the presence of anti-HSP65 MoAb and the fluorescence of the negative control cells stained only with the FITC-conjugated anti-mouse IgG. Daudi, U937 and HPC cells constitutively expressed significant levels of HSP65, while HSP membrane expression on normal H9 was low. However, heat shock treatment of H9 cells increased membrane HSP65 expression. Effect of anti-HSP65 immunotoxin on ex vivo tumour cells Experiments were performed to obtain direct evidence that tumour cells freshly collected ex vivo are susceptible to the inhibitory activity of anti-HSP65 immunotoxin. Daudi and HPC cells were injected into SCID mice; after 15-20 days, when ascites or solid tumour could be observed, cells were harvested from animals and immediately tested with anti-HSP65 immunotoxin in the cell proliferation assay. Figure 5 shows that the proliferation of cells either cultured in vitro or freshly collected ex vivo was inhibited by the anti-HSP65 immunotoxin.
Discussion
Although the presence of HSP in the intracytoplasmatic and nuclear compartments is well documented (Lindquist & Craig, 1988), little information is available so far on HSP membrane expression. The membrane localisation of HSP was observed directly by immunofluorescence on activated mononuclear phagocytes (Wurttenberg et al., 1991) and in the course of viral infections (La Thangue & Latchman, 1988) , and indirectly by the fact that TT/6 lymphocytes recognises HSP on Daudi cells (Fish et al., 1990) . In this context, HSP recognition might represent a mechanism for the role of HSP in autoimmunity and microbial infections (Kaufmann, 1990) . We recently reported that human lymphoma cells express membrane HSP70 and HSP65 representing a molecular target for antibody dependent cellular cytotoxicity (Poccia et al., submitted) . This observation prompted us to investigate the use of immunotoxins directed towards the molecular target of HSP expressed in tumour cells.
There is direct correlation between immunofluorescence The specificity of HSP65 immunotoxin effects on Daudi, H9, and U937 cells is clearly documented by the lack of cell proliferation inhibitory activity when only free saporin, saporin plus uncoupled anti-HSP65 or irrelevant (BC2) immunotoxin were used. The efficiency of saporin-coupled immunotoxins either as anti-HSP65 (direct immunotoxin) or anti-human/mouse Ig (indirect immunotoxins) on all tumour lines tested so far is clearly indicated by the fact that saporinconjugates are easily internalised (Tazzari et al., 1988) . This fact can be correlated with the observation that saporincoupled anti-CD4 and CD8 antibodies inhibit human lymphocyte proliferation . Development of immunotoxin methodology is mainly limited by tumour antigen specificity. In this context, the broad specificity of anti-HSP immunotoxin might be to advantage, although cell lines expressing little or no HSP do not appear to be susceptible to killing in this system. However, TNF or other cytokines (Ferm et al., in press ) are able to increase HSP synthesis in tumour cells, and this may be one way to increase immunotoxin activity. Membrane HSP expression by tumour cells may be considered a phenomenon of in vitro cultured cells. For this reason we transplanted Daudi and HPC cells in SCID mice and tested the explanted cells for HSP expression immediately after removal from the animals. Our results showed that such tumour cells express HSP65 in vivo and can be inhibited by immunotoxin. Thus, the human/SCID model may be helpful to evaluate the immunotoxin approach in vivo, considering also the lack of immune response against toxin in this strain of mice. Preliminary experiments in vivo, where human HPC cells have been growing subcutaneously in SCID mice, showed that daily s.c. injection of anti-HSP65 immunotoxin leads to tumour reduction after one week of treatment (Poccia et al., in preparation) .
Several saporin-containing immunotoxins against specific cell antigens have been prepared. Besides those quoted above (Tazzari et al., 1989; Barbieri et al., 1989) , an anti-CD30-saporin immunotoxin was shown to be highly effective on Reed-Sternbery-derived cells used as target in vitro (Tazzari et al., in press ). Moreover, it was also effective when administered in vivo to patients with Hodgkin's lymphoma (Falini et al., in press ). Present results show that an anti-HSP65-saporin immunotoxin may recognise transformed cells, thus suggesting that it might be possible to develop immunotoxins active against a large panel of tumour cells, in contrast to immunotoxins recognising only specific single tumours.
